GSK & Sanofi Back for a Phase 2 Vaccine Trial in U.S., Honduras & Panama Financed by U.S. Gov
Two major European pharmaceutical manufacturers, France-based Sanofi and UK-based GlaxoSmithKline (GSK) found setbacks toward the end of 2020 with an […]
Two major European pharmaceutical manufacturers, France-based Sanofi and UK-based GlaxoSmithKline (GSK) found setbacks toward the end of 2020 with an […]
Germany-based CureVac, the global biopharmaceutical company developing novel transformative medicines based on messenger ribonucleic acid (“mRNA), including a high potential […]
A San Francisco-based infectious disease-focused biotech called Vir Biotechnology (Nasdaq: VIR)(Vir) teamed with UK-based pharmaceutical giant GlaxoSmithKline (LSE/NSE:GSK) to inform […]
Introducing the Physicians for Civil Defense: Prominent Doctors Know #Ivermectin can Help Treat COVID-19: Will Anyone Listen?A group calling […]
Publicly traded Vir Biotechnology (Nasdaq: VIR) and GlaxoSmithKline plc (LSE/NYSE: GSK) announced the first patient was dosed in a Phase […]
Korean prosecutors have raided GlaxoSmithKline’s (GSK) vaccine division offices according to inside reporting. Although not public, speculation centers on an […]
European pharmaceutical giants recently inked a letter of intent to develop an adjuvanted vaccine for COVID-19, using innovative technology from […]
Leveraging its capital, global reach, and functional genomics expertise, GlaxoSmithKline will inject $250 million into Vir Biotechnology, and its proprietary […]
GlaxoSmithKline (GSK) announced a five-year collaboration with UC Berkeley and UCSF to establish a laboratory where state-of-the-art CRISPR techniques will […]
The UK government reported that GSK’s Belimumab (Benlysta) have revealed in clinical trials to show an increased risk of depression, […]